Status:
COMPLETED
Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG
Lead Sponsor:
Samsung Medical Center
Conditions:
Bowel Preparation
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Proper bowel cleansing before colonoscopy is an important factor to increase the detection rate of lesions. Low volume polyethylene glycol (PEG) plus ascorbic (PEG-Asc) has reduced the dosage of previ...
Detailed Description
Eligibility criteria: outpatients between the ages of 20 and 70 years, who were scheduled for colonoscopy between August 2017 and January 2018 Exclusion criteria: patients with a history of gastroint...
Eligibility Criteria
Inclusion
- outpatients who were scheduled for colonoscopy between August 2017 and January 2018
Exclusion
- History of gastrointestinal tract surgery
- History of inflammatory bowel disease
- History of severe active colitis
- History of chronic kidney disease
- pregnant woman.
Key Trial Info
Start Date :
July 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2018
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT03849196
Start Date
July 31 2017
End Date
January 30 2018
Last Update
February 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351